|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
389 a.a.
|
 |
|
|
|
|
|
|
|
214 a.a.
|
 |
|
|
|
|
|
|
|
221 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase(o-glycosyl)
|
 |
|
Title:
|
 |
Refined crystal structure of the influenza virus n9 neuraminidase-nc41 fab complex
|
|
Structure:
|
 |
Influenza a subtype n9 neuraminidase. Chain: n. Igg2a-kappa nc41 fab (light chain). Chain: l. Igg2a-kappa nc41 fab (heavy chain). Chain: h
|
|
Source:
|
 |
Influenza a virus. Organism_taxid: 11484. Strain: (a/whale/maine/1/84(h13n9)). Mus musculus. House mouse. Organism_taxid: 10090. Organism_taxid: 10090
|
|
Biol. unit:
|
 |
Dodecamer (from
)
|
|
Resolution:
|
 |
|
|
Authors:
|
 |
W.R.Tulip,J.N.Varghese,P.M.Colman
|
Key ref:
|
 |
W.R.Tulip
et al.
(1992).
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.
J Mol Biol,
227,
122-148.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
21-Jan-92
|
Release date:
|
31-Jan-94
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P05803
(NRAM_I84A1) -
Neuraminidase from Influenza A virus (strain A/Whale/Maine/1/1984 H13N9)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
470 a.a.
389 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain N:
E.C.3.2.1.18
- exo-alpha-sialidase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of alpha-(2->3)-, alpha-(2->6)-, alpha-(2->8)-glycosidic linkages of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid and synthetic substrates.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
227:122-148
(1992)
|
|
PubMed id:
|
|
|
|
|
| |
|
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.
|
|
W.R.Tulip,
J.N.Varghese,
W.G.Laver,
R.G.Webster,
P.M.Colman.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of the complex between neuraminidase from influenza virus
(subtype N9 and isolated from an avian source) and the antigen-binding fragment
(Fab) of monoclonal antibody NC41 has been refined by both least-squares and
simulated annealing methods to an R-factor of 0.191 using 31,846 diffraction
data in the resolution range 8.0 to 2.5 A. The resulting model has a
root-mean-square deviation from ideal bond-length of 0.016 A. One fourth of the
tetrameric complex comprises the crystallographic model, which has 6577
non-hydrogen atoms and consists of 389 protein residues and eight carbohydrate
residues in the neuraminidase, 214 residues in the Fab light chain, and 221
residues in the heavy chain. One putative Ca ion buried in the neuraminidase,
and 73 water molecules, are also included. A remarkable shape complementarity
exists between the interacting surfaces of the antigen and the antibody,
although the packing density of atoms at the interface is somewhat looser than
in the interior of a protein. Similarly, there is a high degree of chemical
complementarity between the antigen and antibody, mediated by one buried
salt-link, two solvated salt-links and 12 hydrogen bonds. The antibody-binding
site on neuraminidase is discontinuous and comprises five chain segments and 19
residues in contact, whilst 33 neuraminidase residues in eight segments have 899
A2 of surface area buried by the interaction (to a 1.7 A probe), including two
hexose units. Seventeen residues in NC41 Fab lying in five of the six
complementarity determining regions (CDRs) make contact with the neuraminidase
and 36 antibody residues in seven segments have 916 A2 of buried surface area.
The interface is more extensive than those of the three lysozyme-Fab complexes
whose crystal structures have been determined, as judged by buried surface area
and numbers of contact residues. There are only small differences (less than 1.5
A) between the complexed and uncomplexed neuraminidase structures and, at this
resolution and accuracy, those differences are not unequivocal. The main-chain
conformations of five of the CDRs follow the predicted canonical structures. The
interface between the variable domains of the light and heavy chains is not as
extensive as in other Fabs, due to less CDR-CDR interaction in NC41. The first
CDR on the NC41 Fab light chain is positioned so that it could sterically hinder
the approach of small as well as large substrates to the neuraminidase
active-site pocket, suggesting a possible mechanism for the observed inhibition
of enzyme activity by the antibody.(ABSTRACT TRUNCATED AT 400 WORDS)
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 6.
Figure 6. c'' trace of the tetrameric complex between N9 neuraminidase (yellow) and the 4 NC41 Fabs (heavy chains
ed, light chains blue and CDRs green) with the 4-fold axis approximately vertical. An asymmetric unit contains only
one fo&th of the tetramer.
|
 |
Figure 8.
Figure 8. The epitope region of neuraminidase in the
tern E9%NC41 Fab complex (green) is shown with the
corresponding residues from the uncomplexed N9 struc-
ture overlaid (pink). Yellow labels are laced on resiues
that may have different conformations in the 2 structures
as judged by eletron-density maps. None of these differ-
ences is unequivocal.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(1992,
227,
122-148)
copyright 1992.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Sircar,
and
J.J.Gray
(2010).
SnugDock: paratope structural optimization during antibody-antigen docking compensates for errors in antibody homology models.
|
| |
PLoS Comput Biol,
6,
e1000644.
|
 |
|
|
|
|
 |
J.L.Cherry,
D.J.Lipman,
A.Nikolskaya,
and
Y.I.Wolf
(2009).
Evolutionary dynamics of N-glycosylation sites of influenza virus hemagglutinin.
|
| |
PLoS Curr,
1,
RRN1001.
|
 |
|
|
|
|
 |
K.S.Harris,
J.L.Casey,
A.M.Coley,
J.A.Karas,
J.K.Sabo,
Y.Y.Tan,
O.Dolezal,
R.S.Norton,
A.B.Hughes,
D.Scanlon,
and
M.Foley
(2009).
Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.
|
| |
J Biol Chem,
284,
9361-9371.
|
 |
|
|
|
|
 |
X.Xu,
X.Zhu,
R.A.Dwek,
J.Stevens,
and
I.A.Wilson
(2008).
Structural characterization of the 1918 influenza virus H1N1 neuraminidase.
|
| |
J Virol,
82,
10493-10501.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Piekarska,
A.Drozd,
L.Konieczny,
M.Król,
W.Jurkowski,
I.Roterman,
P.Spólnik,
B.Stopa,
and
J.Rybarska
(2006).
The indirect generation of long-distance structural changes in antibodies upon their binding to antigen.
|
| |
Chem Biol Drug Des,
68,
276-283.
|
 |
|
|
|
|
 |
Z.Xu,
S.Fang,
H.Shi,
H.Li,
Y.Deng,
Y.Liao,
J.M.Wu,
H.Zheng,
H.Zhu,
H.M.Chen,
S.Y.Tsang,
and
H.Xue
(2005).
Topology characterization of a benzodiazepine-binding beta-rich domain of the GABAA receptor alpha1 subunit.
|
| |
Protein Sci,
14,
2622-2637.
|
 |
|
|
|
|
 |
M.Król,
I.Roterman,
B.Piekarska,
L.Konieczny,
J.Rybarska,
and
B.Stopa
(2003).
Local and long-range structural effects caused by the removal of the N-terminal polypeptide fragment from immunoglobulin L chain lambda.
|
| |
Biopolymers,
69,
189-200.
|
 |
|
|
|
|
 |
H.Oliva,
B.Moltedo,
P.De Ioannes,
F.Faunes,
A.E.De Ioannes,
and
M.I.Becker
(2002).
Monoclonal antibodies to molluskan hemocyanin from Concholepas concholepas demonstrate common and specific epitopes among subunits.
|
| |
Hybrid Hybridomics,
21,
365-374.
|
 |
|
|
|
|
 |
J.Valjakka,
K.Takkinenz,
T.Teerinen,
H.Söderlund,
and
J.Rouvinen
(2002).
Structural insights into steroid hormone binding: the crystal structure of a recombinant anti-testosterone Fab fragment in free and testosterone-bound forms.
|
| |
J Biol Chem,
277,
4183-4190.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
U.Gulati,
C.C.Hwang,
L.Venkatramani,
S.Gulati,
S.J.Stray,
J.T.Lee,
W.G.Laver,
A.Bochkarev,
A.Zlotnick,
and
G.M.Air
(2002).
Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).
|
| |
J Virol,
76,
12274-12280.
|
 |
|
|
|
|
 |
R.Norel,
F.Sheinerman,
D.Petrey,
and
B.Honig
(2001).
Electrostatic contributions to protein-protein interactions: fast energetic filters for docking and their physical basis.
|
| |
Protein Sci,
10,
2147-2161.
|
 |
|
|
|
|
 |
B.Tchernychev,
A.Rabinkov,
T.Miron,
and
M.Wilchek
(2000).
Natural antibodies against alliinase in human serum and polyclonal antibodies elicited in rabbit share the same immunogenic determinants.
|
| |
Immunol Lett,
71,
43-47.
|
 |
|
|
|
|
 |
D.W.Ritchie,
and
G.J.Kemp
(2000).
Protein docking using spherical polar Fourier correlations.
|
| |
Proteins,
39,
178-194.
|
 |
|
|
|
|
 |
M.T.Hearn,
and
P.T.Gomme
(2000).
Molecular architecture and biorecognition processes of the cystine knot protein superfamily: part I. The glycoprotein hormones.
|
| |
J Mol Recognit,
13,
223-278.
|
 |
|
|
|
|
 |
R.H.Meloen,
W.C.Puijk,
and
J.W.Slootstra
(2000).
Mimotopes: realization of an unlikely concept.
|
| |
J Mol Recognit,
13,
352-359.
|
 |
|
|
|
|
 |
S.N.Seal,
M.Monestier,
and
M.Z.Radic
(2000).
Diverse roles for the third complementarity determining region of the heavy chain (H3) in the binding of immunoglobulin Fv fragments to DNA, nucleosomes and cardiolipin.
|
| |
Eur J Immunol,
30,
3432-3440.
|
 |
|
|
|
|
 |
A.J.Jesaitis,
D.Gizachew,
E.A.Dratz,
D.W.Siemsen,
K.C.Stone,
and
J.B.Burritt
(1999).
Actin surface structure revealed by antibody imprints: evaluation of phage-display analysis of anti-actin antibodies.
|
| |
Protein Sci,
8,
760-770.
|
 |
|
|
|
|
 |
H.Kondo,
M.Shiroishi,
M.Matsushima,
K.Tsumoto,
and
I.Kumagai
(1999).
Crystal structure of anti-Hen egg white lysozyme antibody (HyHEL-10) Fv-antigen complex. Local structural changes in the protein antigen and water-mediated interactions of Fv-antigen and light chain-heavy chain interfaces.
|
| |
J Biol Chem,
274,
27623-27631.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Li,
A.Llera,
E.L.Malchiodi,
and
R.A.Mariuzza
(1999).
The structural basis of T cell activation by superantigens.
|
| |
Annu Rev Immunol,
17,
435-466.
|
 |
|
|
|
|
 |
J.Thatte,
A.Qadri,
C.Radu,
and
E.S.Ward
(1999).
Molecular requirements for T cell recognition by a major histocompatibility complex class II-restricted T cell receptor: the involvement of the fourth hypervariable loop of the Valpha domain.
|
| |
J Exp Med,
189,
509-520.
|
 |
|
|
|
|
 |
Z.C.Fan,
L.Shan,
B.Z.Goldsteen,
L.W.Guddat,
A.Thakur,
N.F.Landolfi,
M.S.Co,
M.Vasquez,
C.Queen,
P.A.Ramsland,
and
A.B.Edmundson
(1999).
Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-gamma-interferon antibody.
|
| |
J Mol Recognit,
12,
19-32.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
H.Li,
A.Llera,
D.Tsuchiya,
L.Leder,
X.Ysern,
P.M.Schlievert,
K.Karjalainen,
and
R.A.Mariuzza
(1998).
Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B.
|
| |
Immunity,
9,
807-816.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Ysern,
H.Li,
and
R.A.Mariuzza
(1998).
Imperfect interfaces.
|
| |
Nat Struct Biol,
5,
412-414.
|
 |
|
|
|
|
 |
A.L.Corper,
M.K.Sohi,
V.R.Bonagura,
M.Steinitz,
R.Jefferis,
A.Feinstein,
D.Beale,
M.J.Taussig,
and
B.J.Sutton
(1997).
Structure of human IgM rheumatoid factor Fab bound to its autoantigen IgG Fc reveals a novel topology of antibody-antigen interaction.
|
| |
Nat Struct Biol,
4,
374-381.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.H.Trinh,
S.D.Hemmington,
M.E.Verhoeyen,
and
S.E.Phillips
(1997).
Antibody fragment Fv4155 bound to two closely related steroid hormones: the structural basis of fine specificity.
|
| |
Structure,
5,
937-948.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.A.Wilson,
and
K.C.Garcia
(1997).
T-cell receptor structure and TCR complexes.
|
| |
Curr Opin Struct Biol,
7,
839-848.
|
 |
|
|
|
|
 |
P.M.Colman
(1997).
Virus versus antibody.
|
| |
Structure,
5,
591-593.
|
 |
|
|
|
|
 |
C.Tenette,
F.Ducancel,
and
J.C.Smith
(1996).
Structural model of the anti-snake-toxin antibody, M alpha 2,3.
|
| |
Proteins,
26,
9.
|
 |
|
|
|
|
 |
D.R.Davies,
and
G.H.Cohen
(1996).
Interactions of protein antigens with antibodies.
|
| |
Proc Natl Acad Sci U S A,
93,
7.
|
 |
|
|
|
|
 |
P.Bork,
A.K.Downing,
B.Kieffer,
and
I.D.Campbell
(1996).
Structure and distribution of modules in extracellular proteins.
|
| |
Q Rev Biophys,
29,
119-167.
|
 |
|
|
|
|
 |
S.Chacko,
E.W.Silverton,
S.J.Smith-Gill,
D.R.Davies,
K.A.Shick,
K.A.Xavier,
R.C.Willson,
P.D.Jeffrey,
C.Y.Chang,
L.C.Sieker,
and
S.Sheriff
(1996).
Refined structures of bobwhite quail lysozyme uncomplexed and complexed with the HyHEL-5 Fab fragment.
|
| |
Proteins,
26,
55-65.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.A.Kortt,
R.E.Guthrie,
M.G.Hinds,
B.E.Power,
N.Ivancic,
J.B.Caldwell,
L.C.Gruen,
R.S.Norton,
and
P.J.Hudson
(1995).
Solution properties of Escherichia coli-expressed VH domain of anti-neuraminidase antibody NC41.
|
| |
J Protein Chem,
14,
167-178.
|
 |
|
|
|
|
 |
J.Janin
(1995).
Elusive affinities.
|
| |
Proteins,
21,
30-39.
|
 |
|
|
|
|
 |
K.P.Murphy,
E.Freire,
and
Y.Paterson
(1995).
Configurational effects in antibody-antigen interactions studied by microcalorimetry.
|
| |
Proteins,
21,
83-90.
|
 |
|
|
|
|
 |
L.C.Kovari,
C.Momany,
and
M.G.Rossmann
(1995).
The use of antibody fragments for crystallization and structure determinations.
|
| |
Structure,
3,
1291-1293.
|
 |
|
|
|
|
 |
S.V.Kashmiri,
L.Shu,
E.A.Padlan,
D.E.Milenic,
J.Schlom,
and
P.H.Hand
(1995).
Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.
|
| |
Hybridoma,
14,
461-473.
|
 |
|
|
|
|
 |
A.A.Kortt,
R.L.Malby,
J.B.Caldwell,
L.C.Gruen,
N.Ivancic,
M.C.Lawrence,
G.J.Howlett,
R.G.Webster,
P.J.Hudson,
and
P.M.Colman
(1994).
Recombinant anti-sialidase single-chain variable fragment antibody. Characterization, formation of dimer and higher-molecular-mass multimers and the solution of the crystal structure of the single-chain variable fragment/sialidase complex.
|
| |
Eur J Biochem,
221,
151-157.
|
 |
|
|
|
|
 |
A.R.Friedman,
V.A.Roberts,
and
J.A.Tainer
(1994).
Predicting molecular interactions and inducible complementarity: fragment docking of Fab-peptide complexes.
|
| |
Proteins,
20,
15-24.
|
 |
|
|
|
|
 |
C.Eigenbrot,
T.Gonzalez,
J.Mayeda,
P.Carter,
W.Werther,
T.Hotaling,
J.Fox,
and
J.Kessler
(1994).
X-ray structures of fragments from binding and nonbinding versions of a humanized anti-CD18 antibody: structural indications of the key role of VH residues 59 to 65.
|
| |
Proteins,
18,
49-62.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.Cherfils,
T.Bizebard,
M.Knossow,
and
J.Janin
(1994).
Rigid-body docking with mutant constraints of influenza hemagglutinin with antibody HC19.
|
| |
Proteins,
18,
8.
|
 |
|
|
|
|
 |
J.F.Schildbach,
S.Y.Shaw,
R.E.Bruccoleri,
E.Haber,
L.A.Herzenberg,
G.C.Jager,
P.D.Jeffrey,
D.J.Panka,
D.R.Parks,
and
R.I.Near
(1994).
Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.
|
| |
Protein Sci,
3,
737-749.
|
 |
|
|
|
|
 |
P.M.Colman
(1994).
Influenza virus neuraminidase: structure, antibodies, and inhibitors.
|
| |
Protein Sci,
3,
1687-1696.
|
 |
|
|
|
|
 |
R.L.Malby,
W.R.Tulip,
V.R.Harley,
J.L.McKimm-Breschkin,
W.G.Laver,
R.G.Webster,
and
P.M.Colman
(1994).
The structure of a complex between the NC10 antibody and influenza virus neuraminidase and comparison with the overlapping binding site of the NC41 antibody.
|
| |
Structure,
2,
733-746.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.J.Hubbard,
and
P.Argos
(1994).
Cavities and packing at protein interfaces.
|
| |
Protein Sci,
3,
2194-2206.
|
 |
|
|
|
|
 |
T.N.Bhat,
G.A.Bentley,
G.Boulot,
M.I.Greene,
D.Tello,
W.Dall'Acqua,
H.Souchon,
F.P.Schwarz,
R.A.Mariuzza,
and
R.J.Poljak
(1994).
Bound water molecules and conformational stabilization help mediate an antigen-antibody association.
|
| |
Proc Natl Acad Sci U S A,
91,
1089-1093.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
T.Saito,
G.Taylor,
W.G.Laver,
Y.Kawaoka,
and
R.G.Webster
(1994).
Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase.
|
| |
J Virol,
68,
1790-1796.
|
 |
|
|
|
|
 |
V.C.Yee,
L.C.Pedersen,
I.Le Trong,
P.D.Bishop,
R.E.Stenkamp,
and
D.C.Teller
(1994).
Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII.
|
| |
Proc Natl Acad Sci U S A,
91,
7296-7300.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.C.Dougall,
N.C.Peterson,
and
M.I.Greene
(1994).
Antibody-structure-based design of pharmacological agents.
|
| |
Trends Biotechnol,
12,
372-379.
|
 |
|
|
|
|
 |
J.M.Nuss,
P.B.Whitaker,
and
G.M.Air
(1993).
Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase.
|
| |
Proteins,
15,
121-132.
|
 |
|
|
|
|
 |
L.C.Gruen,
A.A.Kortt,
and
E.Nice
(1993).
Determination of relative binding affinity of influenza virus N9 sialidases with the Fab fragment of monoclonal antibody NC41 using biosensor technology.
|
| |
Eur J Biochem,
217,
319-325.
|
 |
|
|
|
|
 |
R.A.Mariuzza,
and
R.J.Poljak
(1993).
The basics of binding: mechanisms of antigen recognition and mimicry by antibodies.
|
| |
Curr Opin Immunol,
5,
50-55.
|
 |
|
|
|
|
 |
R.L.Malby,
J.B.Caldwell,
L.C.Gruen,
V.R.Harley,
N.Ivancic,
A.A.Kortt,
G.G.Lilley,
B.E.Power,
R.G.Webster,
and
P.M.Colman
(1993).
Recombinant antineuraminidase single chain antibody: expression, characterization, and crystallization in complex with antigen.
|
| |
Proteins,
16,
57-63.
|
 |
|
|
|
|
 |
R.L.Stanfield,
M.Takimoto-Kamimura,
J.M.Rini,
A.T.Profy,
and
I.A.Wilson
(1993).
Major antigen-induced domain rearrangements in an antibody.
|
| |
Structure,
1,
83-93.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |
|